# SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)

> **NCT06646770** · NA · NOT_YET_RECRUITING · sponsor: **Istanbul University - Cerrahpasa** · enrollment: 400 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Segmentectomy
- **PROCEDURE:** Lobectomy

## Key facts

- **NCT ID:** NCT06646770
- **Lead sponsor:** Istanbul University - Cerrahpasa
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-02
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646770, "SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06646770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
